Sandbox DL: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(6 intermediate revisions by one other user not shown)
Line 2: Line 2:
{{Bone or cartilage mass}}
{{Bone or cartilage mass}}
{{CMG}} {{AE}} {{DL}}
{{CMG}} {{AE}} {{DL}}
==Overview==
According to the Enneking system there are 6 stages of benign and malignant bone tumors based on the grade, anatomic site, and metastasis.<ref name="enneking">Enneking System for Staging of Benign and Malignant Bone and Soft Tissue Lesion. Orthopaedics One. http://www.orthopaedicsone.com/x/TwAjAQ. Accessed on February 12, 2016 </ref>


==Staging==
==Staging==
 
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center"
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
|+ '''Enneking Tumor Staging''' <br><SMALL>Adapted from The Orthopaedic Knowledge Network. 2009  <ref name="enneking">Enneking System for Staging of Benign and Malignant Bone and Soft Tissue Lesion. Orthopaedics One. http://www.orthopaedicsone.com/x/TwAjAQ. Accessed on February 12, 2016 </ref></SMALL>
|+ '''Tumor Staging''  
! rowspan="3" style="width: 120px;font-weight: bold;background: #DCDCDC" | Grade
! rowspan="3" style="width: 120px;font-weight: bold;background: #DCDCDC" | Grade
| style="background: #F5F5F5; text-align:center" | '''G0'''
| style="background: #F5F5F5; text-align:center" | '''G0'''
Line 36: Line 38:
|}
|}


{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center"
|+ '''Tumor Staging''  
|+ '''Enneking Tumor Staging''' <br><SMALL>Adapted from The Orthopaedic Knowledge Network. 2009  <ref name="enneking">Enneking System for Staging of Benign and Malignant Bone and Soft Tissue Lesion. Orthopaedics One. http://www.orthopaedicsone.com/x/TwAjAQ. Accessed on February 12, 2016 </ref></SMALL>
! style="width: 180px;background: #4479BA" |{{fontcolor|#FFF| Origin}}
! style="width: 180px;background: #4479BA" |{{fontcolor|#FFF| Origin}}
! style="width: 120px;background: #4479BA" |{{fontcolor|#FFF| Stages}}
! style="width: 120px;background: #4479BA" |{{fontcolor|#FFF| Stages}}
Line 46: Line 48:
! style="width: 120px;background: #4479BA" |{{fontcolor|#FFF| Examples}}
! style="width: 120px;background: #4479BA" |{{fontcolor|#FFF| Examples}}
|-
|-
| style="width: 120px;font-weight: bold;background: #DCDCDC" | Benign
| rowspan="3" style="width: 120px;font-weight: bold;background: #DCDCDC" | Benign
| style="width: 120px;font-weight: bold;background: #DCDCDC" | 1
| style="width: 120px;font-weight: bold;background: #DCDCDC" | 1
| style="background: #F5F5F5; text-align:center" | G0
| style="background: #F5F5F5; text-align:center" | G0
Line 54: Line 56:
| style="background: #F5F5F5; text-align:center" | Osteoid osteoma, lipoma
| style="background: #F5F5F5; text-align:center" | Osteoid osteoma, lipoma
|-
|-
| style="width: 120px;font-weight: bold;background: #DCDCDC" | Benign
| style="width: 120px;font-weight: bold;background: #DCDCDC" | 2
| style="width: 120px;font-weight: bold;background: #DCDCDC" | 2
| style="background: #F5F5F5; text-align:center" | G0
| style="background: #F5F5F5; text-align:center" | G0
Line 62: Line 63:
| style="background: #F5F5F5; text-align:center" | Giant cell tumor, hemangioma
| style="background: #F5F5F5; text-align:center" | Giant cell tumor, hemangioma
|-
|-
| style="width: 120px;font-weight: bold;background: #DCDCDC" | Benign
| style="width: 120px;font-weight: bold;background: #DCDCDC" | 3
| style="width: 120px;font-weight: bold;background: #DCDCDC" | 3
| style="background: #F5F5F5; text-align:center" | G0
| style="background: #F5F5F5; text-align:center" | G0
Line 70: Line 70:
| style="background: #F5F5F5; text-align:center" | Desmoplastic fibroma, chondroblastoma
| style="background: #F5F5F5; text-align:center" | Desmoplastic fibroma, chondroblastoma
|-
|-
| style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant
| rowspan="6" style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IA
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IA
| style="background: #F5F5F5; text-align:center" | G1
| style="background: #F5F5F5; text-align:center" | G1
Line 78: Line 78:
| style="background: #F5F5F5; text-align:center" | Low grade intramedullary osteosarcoma, dematofibrosarcoma protuberans
| style="background: #F5F5F5; text-align:center" | Low grade intramedullary osteosarcoma, dematofibrosarcoma protuberans
|-
|-
| style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IB
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IB
| style="background: #F5F5F5; text-align:center" | G1
| style="background: #F5F5F5; text-align:center" | G1
Line 86: Line 85:
| style="background: #F5F5F5; text-align:center" | Parosteal osteosarcoma, hemangioendothelioma
| style="background: #F5F5F5; text-align:center" | Parosteal osteosarcoma, hemangioendothelioma
|-
|-
| style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IIA
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IIA
| style="background: #F5F5F5; text-align:center" | G2
| style="background: #F5F5F5; text-align:center" | G2
Line 94: Line 92:
| style="background: #F5F5F5; text-align:center" | High grade central osteosarcoma, angiomatoid malignant fibrous histiocytoma
| style="background: #F5F5F5; text-align:center" | High grade central osteosarcoma, angiomatoid malignant fibrous histiocytoma
|-
|-
| style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IIB
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IIB
| style="background: #F5F5F5; text-align:center" | G2
| style="background: #F5F5F5; text-align:center" | G2
Line 102: Line 99:
| style="background: #F5F5F5; text-align:center" | Ewing sarcoma, high grade osteosarcoma
| style="background: #F5F5F5; text-align:center" | Ewing sarcoma, high grade osteosarcoma
|-
|-
| style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IIIA
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IIIA
| style="background: #F5F5F5; text-align:center" | G1-G2
| style="background: #F5F5F5; text-align:center" | G1-G2
Line 110: Line 106:
| style="background: #F5F5F5; text-align:center" | Low grade intramedullary osteosarcoma, low grade synovial sarcoma
| style="background: #F5F5F5; text-align:center" | Low grade intramedullary osteosarcoma, low grade synovial sarcoma
|-
|-
| style="width: 120px;font-weight: bold;background: #DCDCDC" | Malignant
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IIIB
| style="width: 120px;font-weight: bold;background: #DCDCDC" | IIIB
| style="background: #F5F5F5; text-align:center" | G1-G2
| style="background: #F5F5F5; text-align:center" | G1-G2
Line 118: Line 113:
| style="background: #F5F5F5; text-align:center" | High grade osteosarcoma, high grade liposarcoma
| style="background: #F5F5F5; text-align:center" | High grade osteosarcoma, high grade liposarcoma
|}
|}
==References==
{{reflist|1}}

Latest revision as of 20:12, 17 February 2016

Bone or Cartilage Mass Microchapters

Home

Patient Information

Overview

Classification

Causes

Differential Diagnosis

Epidemiology and Demographics

Screening

Diagnosis

Evaluation of Bone or Cartilage Mass

Staging

History and Symptoms

Physical Examination

Laboratory Studies

Imaging

Biopsy

Other Diagnostic Studies

Case Studies

Case #1

Sandbox DL On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox DL

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox DL

CDC on Sandbox DL

Sandbox DL in the news

Blogs on Sandbox DL

Directions to Hospitals Treating bone or soft tissue mass

Risk calculators and risk factors for Sandbox DL

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Danitza Lukac

Overview

According to the Enneking system there are 6 stages of benign and malignant bone tumors based on the grade, anatomic site, and metastasis.[1]

Staging

Enneking Tumor Staging
Adapted from The Orthopaedic Knowledge Network. 2009 [1]
Grade G0 Benign
G1 Low grade malignant
G2 High grade malignant
Anatomic site T0 Intracapsular
T1 Extracapsular, intracompartmental
T2 Extracapsular, extracompartmental
Metastasis M0 No metastasis
M1 Distant metastasis
Enneking Tumor Staging
Adapted from The Orthopaedic Knowledge Network. 2009 [1]
Origin Stages Grade Site Metastasis Description Examples
Benign 1 G0 T0 M0 Benign latent Osteoid osteoma, lipoma
2 G0 T0 M0 Benign active Giant cell tumor, hemangioma
3 G0 T1-T2 M0-M1 Benign aggresive Desmoplastic fibroma, chondroblastoma
Malignant IA G1 T1 M0 Low grade malignant, intracompartmental Low grade intramedullary osteosarcoma, dematofibrosarcoma protuberans
IB G1 T2 M0 Low grade malignant, extracompartmental Parosteal osteosarcoma, hemangioendothelioma
IIA G2 T1 M0 High grade malignant, intracompartmental High grade central osteosarcoma, angiomatoid malignant fibrous histiocytoma
IIB G2 T2 M0 High grade malignant, extracompartmental Ewing sarcoma, high grade osteosarcoma
IIIA G1-G2 T1 M1 Regional metastasis Low grade intramedullary osteosarcoma, low grade synovial sarcoma
IIIB G1-G2 T2 M1 Distant metastasis High grade osteosarcoma, high grade liposarcoma

References

  1. 1.0 1.1 1.2 Enneking System for Staging of Benign and Malignant Bone and Soft Tissue Lesion. Orthopaedics One. http://www.orthopaedicsone.com/x/TwAjAQ. Accessed on February 12, 2016